EMA’s Revised Guide On Additional Risk Minimization ‘Overly Detailed’
EU Pharma Association Pushes For Greater Use Of Digital Formats
Executive Summary: The European pharma industry federation believes the advice provided in the updated draft EU guideline on additional risk minimization measures is far too detailed, resulting in a lack of focus, information overlap and confusion.
